| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 180 | 0 | 1.596 | 1.010 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 180 | 0 | 1.596 | 1.010 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 4.978 | 4.271 | 2.894 | 932 | 148 | 87 | 0 | 4.185 | 0 | 804 |
| Gross Profit/Loss - EUR | -4.798 | -4.271 | -1.298 | 78 | -148 | -87 | 0 | -4.185 | 0 | -804 |
| Net Profit/Loss - EUR | -4.803 | -4.271 | -1.346 | 47 | -148 | -87 | 0 | -4.185 | 0 | -804 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Z&B Toxicologie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.197 | 7.388 | 4.385 | 3.379 | 3.179 | 3.032 | 2.965 | 2.974 | 2.965 | 2.144 |
| Current Assets | 7.825 | 7.281 | 8.580 | 6.868 | 6.692 | 6.565 | 6.420 | 2.254 | 2.247 | 2.235 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.321 | 7.247 | 7.124 | 4.435 | 4.349 | 4.267 | 4.172 | 0 | 0 | 0 |
| Cash | 504 | 34 | 1.456 | 2.432 | 2.342 | 2.298 | 2.247 | 2.254 | 2.247 | 2.235 |
| Shareholders Funds | 16.344 | 11.907 | 10.359 | 10.217 | 9.871 | 9.597 | 9.384 | 5.228 | 5.212 | 4.379 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 2.678 | 2.762 | 2.606 | 30 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7120 - 7120" | |||||||||
| CAEN Financial Year |
7120
|
|||||||||
Comments - Z&B Toxicologie Srl